Connect

Member Research and Reports

Member Research and Reports

Washington Researcher Finds New Drug Targets Genital Herpes

A new drug has shown effectiveness against the virus that causes genital herpes, according to a study led by Dr. Anna Wald, professor of epidemiology at the University of Washington School of Public Health. The new drug, called pritelivir, inhibits the virus by targeting a different part of the virus’s replication machinery than other currently used drugs. About one in six Americans 14 to 49 years old has herpes simplex virus-2 (HSV-2), according to the Centers for Disease Control and Protection. There are treatments that can reduce transmission and shorten outbreaks, but there is no cure.